Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Enveric Biosciences, Inc. (AMRH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K/A10-K/A8-K10-K/A10-K/A10-K10-K10-K/A
Revenues  0.00.00.039.943.048.619.214.5
            Revenue growth    -100.0%-7.2%-11.5%152.6%32.4%22047.0%
Cost of goods sold  0.00.00.031.834.038.40.00.0
Gross profit  0.00.00.08.29.010.219.214.5
            Gross margin     20.4%20.9%21.1%100.0%100.0%
Selling, general and administrative   [+]11.620.55.412.210.818.512.30.1
Research and development  8.04.80.2     
Other operating expenses      -6.9-1.113.515.5
EBITDA   [+]-19.6-25.3 -4.15.1-7.2-5.2-0.9
            EBITDA margin     -10.2%11.9%-14.8%-26.9%-6.4%
Depreciation  0.20.0 0.00.00.00.00.0
EBITA  -19.8-25.3-5.6-4.05.1-7.2-5.1-0.9
            EBITA margin     -10.1%11.9%-14.8%-26.7%-6.4%
Amortization of intangibles  0.20.6 2.32.93.21.40.2
EBIT   [+]-20.0-25.9-5.6-6.32.2-10.4-6.5-1.1
            EBIT margin     -15.8%5.2%-21.4%-34.0%-7.5%
Non-recurring items   [+]7.538.7  9.40.5  
Interest expense  0.00.00.40.70.70.6  
Other income (expense), net   [+]7.58.2-1.01.8-2.70.00.80.4
Pre-tax income  -20.0-56.4-7.0-5.2-10.5-11.5-6.5-0.9
Income taxes  -1.5-7.50.00.46.3-2.4-3.7-0.1
            Tax rate  7.4%13.2%0.0%  20.9%57.4%13.6%
Minority interest        0.0 
Net income  -18.8-49.0-7.0-6.0-19.5-11.2-2.8-0.8
            Net margin     -15.1%-45.3%-23.0%-14.5%-5.6%
   
Basic EPS   [+]($13.00)($103.69)($1.22)($2.83)($20.47)($0.75)($0.21)($0.07)
Diluted EPS   [+]($13.00)($103.69)($1.22)($2.83)($20.47)($0.75)($0.21)($0.07)
   
Shares outstanding (basic)   [+]1.40.55.82.11.015.013.111.1
Shares outstanding (diluted)   [+]1.40.55.82.11.015.013.111.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy